Stock Scorecard
Stock Summary for Rockwell Medical Inc (RMTI) - $1.09 as of 10/29/2025 9:13:24 PM EST
Total Score
13 out of 30
Safety Score
17 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for RMTI
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RMTI
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RMTI
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for RMTI
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for RMTI (17 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for RMTI
Financial Details for RMTI
Company Overview |
|
|---|---|
| Ticker | RMTI |
| Company Name | Rockwell Medical Inc |
| Country | USA |
| Description | Rockwell Medical, Inc. is an innovative biopharmaceutical company focused on addressing the critical needs of patients with end-stage renal disease and chronic kidney disease through its proprietary iron deficiency treatments and hemodialysis solutions. Based in Wixom, Michigan, Rockwell is committed to advancing healthcare for renal patients, with a growing portfolio of products aimed at enhancing patient outcomes both domestically and internationally. The company's strategic focus on renal health positions it well in a market driven by increasing demand for specialized therapies, making it a key player in the biopharmaceutical landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/17/2025 |
Stock Price History |
|
| Last Day Price | 1.09 |
| Price 4 Years Ago | 4.51 |
| Last Day Price Updated | 10/29/2025 9:13:24 PM EST |
| Last Day Volume | 411,537 |
| Average Daily Volume | 885,372 |
| 52-Week High | 5.15 |
| 52-Week Low | 0.78 |
| Last Price to 52 Week Low | 39.74% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 90.23 |
| Sector PE | 40.93 |
| 5-Year Average PE | -20.61 |
| Free Cash Flow Ratio | 3.03 |
| Industry Free Cash Flow Ratio | 13.79 |
| Sector Free Cash Flow Ratio | 29.03 |
| Current Ratio Most Recent Quarter | 2.89 |
| Total Cash Per Share | 0.36 |
| Book Value Per Share Most Recent Quarter | 0.88 |
| Price to Book Ratio | 1.37 |
| Industry Price to Book Ratio | 11.41 |
| Sector Price to Book Ratio | 32.16 |
| Price to Sales Ratio Twelve Trailing Months | 0.45 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.80 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.96 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 34,430,400 |
| Market Capitalization | 37,529,136 |
| Institutional Ownership | 17.20% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.49% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 94.31% |
| Reported EPS 12 Trailing Months | -0.07 |
| Reported EPS Past Year | -0.07 |
| Reported EPS Prior Year | -0.03 |
| Net Income Twelve Trailing Months | -2,099,000 |
| Net Income Past Year | -480,000 |
| Net Income Prior Year | -8,439,000 |
| Quarterly Revenue Growth YOY | -37.80% |
| 5-Year Revenue Growth | 10.61% |
| Operating Margin Twelve Trailing Months | -8.39% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 12,482,000 |
| Total Cash Past Year | 15,662,000 |
| Total Cash Prior Year | 8,983,000 |
| Net Cash Position Most Recent Quarter | 3,834,000 |
| Net Cash Position Past Year | 7,190,000 |
| Long Term Debt Past Year | 8,472,000 |
| Long Term Debt Prior Year | 8,293,000 |
| Total Debt Most Recent Quarter | 8,648,000 |
| Equity to Debt Ratio Past Year | 0.79 |
| Equity to Debt Ratio Most Recent Quarter | 0.78 |
| Total Stockholder Equity Past Year | 32,586,000 |
| Total Stockholder Equity Prior Year | 21,291,000 |
| Total Stockholder Equity Most Recent Quarter | 30,409,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 2,684,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.08 |
| Free Cash Flow Past Year | 3,191,000 |
| Free Cash Flow Prior Year | -9,696,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.05 |
| MACD Signal | -0.06 |
| 20-Day Bollinger Lower Band | 0.65 |
| 20-Day Bollinger Middle Band | 1.15 |
| 20-Day Bollinger Upper Band | 1.65 |
| Beta | 1.73 |
| RSI | 44.54 |
| 50-Day SMA | 1.53 |
| 150-Day SMA | 2.02 |
| 200-Day SMA | 2.15 |
System |
|
| Modified | 10/28/2025 8:46:19 AM EST |